The MAxL

Our teams

Latest News:

Latest News:

Innovative Ideas On The Way To Market.

Build on the findings of cutting-edge life science research, MAxL is home of currently 12 pre-seed and early-stage teams.

MAxL offers these teams support, infrastructure and the time to develop their ideas into market-ready products.

MAxL - in a nutshell.
 

Where:

- on around 900 m2 in close proximity to BioM 

- since mid-2024 -

What:

- Innovative therapeutics (all forms, including ATMPs such as gene therapy, cell therapy, vaccines)

- Platform technologies for the discovery and development of drugs and for the production of drugs and vaccines

- Next-generation diagnostics and diagnostic platforms

- Health tech business models based on digital health, big data, machine learning and AI

- Biotechnology-based solutions in the field of bioeconomy

How:

- Access to state-of-the-art laboratory infrastructure (including equipment), co-working and event space

- Individual and close support for the founding teams to further develop their technology and business model (incubation)

- Coaching and mentoring by experienced entrepreneurs and experts

- Access to the broad BioM network of start-ups, industry partners, investors, clinics and academic partners

- Training programs tailored to bioentrepreneurs

- Wide range of events for the MAxL community

More on our mandate.